Should you buy Synopsys (SNPS)?
Updated
Synopsys delivers 42% revenue growth and an elite Rule-of-40 score of 83, but the stock is in deep technical distress with RSI at 26 near capitulation levels, consecutive earnings misses, and a forward P/E of 26.3x that prices in a recovery the fundamentals have yet to validate.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
Synopsys achieved 42% year-over-year revenue growth and a Rule-of-40 score of 83 — placing it in the highest echelon of software infrastructure companies globally — with 458% free cash flow conversion of net income reflecting exceptional capital efficiency. Growth breakdown | Revenue growth remains above 25% year-over-year and the Rule-of-40 score stays above 60 for at least 2 of the next 4 reported quarters. | →Stable |
| CounterConsecutive earnings misses in 2 of the last 4 quarters, including a -72.8% EPS miss most recently, suggest the revenue growth narrative has not translated into expected bottom-line execution. | ||
Synopsys has missed EDA analyst earnings estimates in 2 of the last 4 quarters, including a severe -72.8% miss in the most recent quarter, creating a pattern that undermines confidence in near-term earnings predictability. Earnings | The company delivers consecutive earnings beats in at least 2 of the next 3 reported quarters, resetting the estimate credibility. | →Stable |
| CounterThe two beat quarters produced extraordinary surprises of 11.6x and 12.5x, suggesting the miss-beat volatility reflects genuine timing lumpiness in license revenue rather than a structural deterioration in the business. | ||
With RSI at 26, the stock is approaching capitulation territory, trading below all major moving averages with a 200-day slope declining at -3.7% over 30 days and declining on-balance volume — all three technical factors pointing to sustained selling pressure. Momentum breakdown | RSI recovers to above 40 and price reclaims the 200-day moving average within 6 months, signaling the capitulation phase is ending. | →Stable |
| CounterTechnical capitulation at RSI 26 often marks a turning point where forced sellers have been exhausted; Bollinger Band and support/resistance scores of 8.4 and 9.0 indicate the stock is at significant technical support. | ||
Synopsys achieved 42% year-over-year revenue growth and a Rule-of-40 score of 83 — placing it in the highest echelon of software infrastructure companies globally — with 458% free cash flow conversion of net income reflecting exceptional capital efficiency.
→Stable- Expectation
- Revenue growth remains above 25% year-over-year and the Rule-of-40 score stays above 60 for at least 2 of the next 4 reported quarters.
CounterConsecutive earnings misses in 2 of the last 4 quarters, including a -72.8% EPS miss most recently, suggest the revenue growth narrative has not translated into expected bottom-line execution.
Synopsys has missed EDA analyst earnings estimates in 2 of the last 4 quarters, including a severe -72.8% miss in the most recent quarter, creating a pattern that undermines confidence in near-term earnings predictability.
→Stable- Expectation
- The company delivers consecutive earnings beats in at least 2 of the next 3 reported quarters, resetting the estimate credibility.
CounterThe two beat quarters produced extraordinary surprises of 11.6x and 12.5x, suggesting the miss-beat volatility reflects genuine timing lumpiness in license revenue rather than a structural deterioration in the business.
With RSI at 26, the stock is approaching capitulation territory, trading below all major moving averages with a 200-day slope declining at -3.7% over 30 days and declining on-balance volume — all three technical factors pointing to sustained selling pressure.
→Stable- Expectation
- RSI recovers to above 40 and price reclaims the 200-day moving average within 6 months, signaling the capitulation phase is ending.
CounterTechnical capitulation at RSI 26 often marks a turning point where forced sellers have been exhausted; Bollinger Band and support/resistance scores of 8.4 and 9.0 indicate the stock is at significant technical support.
▸ Show 1 more pillar▾ Show fewer
Despite the technical distress, analyst consensus implies 23% upside to $504 from the current $454, and the stock scores 7.0 out of 10 on sentiment — indicating that fundamental analysts see the distress as an overshoot relative to intrinsic value.
→Stable- Expectation
- Price rises above $500, recovering more than 10% from the current $454, within 12 months as the market re-rates on improving earnings visibility.
CounterAnalyst targets may be stale and will be revised downward following the two recent earnings misses; the pending C-suite officer departure flagged in 8-K adds additional uncertainty to the near-term execution picture.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Synopsys achieved 42% year-over-year revenue growth and a Rule-of-40 score of 83 — placing it in the highest echelon of software infrastructure companies globally — with 458% free cash flow conversion of net income reflecting exceptional capital efficiency.
Trip ifRevenue growth falls below 15% year-over-year for 2 consecutive quarters, indicating the growth rate is decelerating sharply from the 42% reported level.
- P2Synopsys has missed EDA analyst earnings estimates in 2 of the last 4 quarters, including a severe -72.8% miss in the most recent quarter, creating a pattern that undermines confidence in near-term earnings predictability.
Trip ifEPS surprise falls below 0% in at least 3 of the next 4 quarters, confirming the miss pattern is structural rather than timing-driven.
- P3With RSI at 26, the stock is approaching capitulation territory, trading below all major moving averages with a 200-day slope declining at -3.7% over 30 days and declining on-balance volume — all three technical factors pointing to sustained selling pressure.
Trip ifPrice drops below $400, more than 12% below the current $454, confirming that the capitulation phase has not yet reached its floor.
- P4Despite the technical distress, analyst consensus implies 23% upside to $504 from the current $454, and the stock scores 7.0 out of 10 on sentiment — indicating that fundamental analysts see the distress as an overshoot relative to intrinsic value.
Trip ifAnalyst consensus price target falls below $430, less than 5% below the current price of $454, indicating that analysts are capitulating on their upside case.
How the engine reached this verdict
TrendMatrix's engine output for Synopsys, Inc. (SNPS) is SELL_IF_HOLDING with medium conviction, score 5.0/10 at $457.19. The F-path SELL output reflects an overall score of 5.0 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of 1.23 is supplementary context, not the trigger.
The engine's exit framework anchors to a tactical sell band near $457.19, with structural invalidation at $431.48. The asymmetric R:R against a reversal hypothesis is 1.75 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bull side: Strong earnings beat streak (3/4); Recent Analyst Cluster(10) detected in news. On the bear side: Expensive valuation. Active engine warnings: V9 Gate Failed: MOMENTUM:4.2<4.5, V9 Gate Failed: ASYMMETRY:1.2<1.5@spot.
The dominant failed gate is momentum at 4.2 vs threshold 4.5 (with co-failures: reward-to-risk). SELL flips back toward HOLD if momentum recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is INSIDER:OK.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates SNPS — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (3/4)
- ▸Recent Analyst Cluster(10) detected in news
Bear case
- ▸Expensive valuation